HUTCHMED (China) (HCM) Goodwill & Intangibles (2014 - 2024)
HUTCHMED (China)'s (HCM) quarterly Goodwill & Intangibles came in at $3.0 million in Q4 2024, down 15.39% on a QoQ basis from $3.5 million in Q4 2020.
HUTCHMED (China) (HCM) Goodwill & Intangibles (2014 - 2024) Analysis & Trends
HUTCHMED (China) (HCM) has 8 years of Goodwill & Intangibles data on file, last reported at $3.0 million in Q4 2024.
- On a quarterly basis, Goodwill & Intangibles changed N/A year-over-year to $3.0 million in Q4 2024; TTM through Dec 2024 was $3.0 million, a N/A change from a year earlier, with the FY2020 full-year figure at $3.5 million, up 4.34% from the prior year.
- Goodwill & Intangibles for Q4 2024 stood at $3.0 million, down from $3.5 million in the prior quarter.
- Over the last five years, Goodwill & Intangibles for HCM reached as high as $3.5 million in Q4 2020 and fell as low as $3.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 2.99 Mn |
| Dec 31, 2020 | 3.53 Mn |
| Dec 31, 2019 | 3.39 Mn |
| Dec 31, 2018 | 3.53 Mn |
| Dec 31, 2017 | 3.74 Mn |
| Dec 31, 2016 | 3.61 Mn |
| Jun 30, 2016 | 3.81 Mn |
| Dec 31, 2015 | 3.90 Mn |
| Dec 31, 2014 | 4.14 Mn |